Ellicott City, MD – At the Society for Clinical Research Sites (SCRS) Asia-Pac Site Solutions Summit in Melbourne, Australia on July 14-15, SCRS and ARCS Australia, announced the signing of an MOU to explore collaboration and promote educational offerings for their respective members. SCRS’ 2017 Asia-Pac Site Solutions Summit will coincide with ACRS’ 2017 National Congress in Sydney. “SCRS represents clinical research sites around the globe. The MOU and planned partnership with ARCS Australia extends the reach of SCRS’ advocacy and education offerings,” said Christine Pierre, President of SCRS. “The members of both organizations will greatly benefit from a partnership and we are thrilled to be forging this relationship with ACRS.” “It’s about what is best for our ARCS members’ said Dr Shanny Dyer, CEO of ARCS Australia. “By setting up a partnership with SCRS we are looking to ensure our members can access information with a focus on sites and have a one-stop knowledge shop.” About SCRS SCRS is a global trade organization founded in 2012 which represents over 2,800 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit MySCRS.org. About ARCS Australia ARCS supports the education, training and networking of individuals and provide representation for member interests for those working in the scientific disciplines of regulation, clinical research, health economics, medical affairs, medical information, pharmacovigilance and associated disciplines in the pharmaceutical and medical devices sectors. Membership is on an individual basis and currently stands at approximately 2,000. Visit ARCS.com.au.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.